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respect to ethical conflict between clinical efficacy and eco- 
nomic cost. 
The book is divided into four sections. The first section 
deals with the development ofthrombolytic agents, begin- 
ning with the pioneering investigations of James Herrick, 
who in 1912 emphasized the association between acute 
coronary artery thrombosis and the clinical syndrome of 
myocardial infarction. Brody follows with an insightful 
account of the evolution of streptokinase, firstreported by 
Tiller and Garner in 1933. The remainder of the section 
outlines the various clinical trials of thrombolysis for coro- 
nary occlusion, including those organized by the NIH and 
those by the pharmaceutical companies. Links between 
investigators and the companies are discussed, naming in- 
dividuals, corporations, and their financial connections in 
the form of stock options. The latest rial of thrombolysis 
for myocardial infarction, the GUSTO trial, is outlined in 
the final portion of the section, discussing the possible 
relationship between Genentech's $55 million investment 
in the study, the unblinded study protocol, and the rather 
modest mortality differences between rt -PA (6.3%) and 
streptokinase (7.2% to 7.4%). 
The second, third, and fourth sections of the text 
describe ethical issues with regard to clinical trials, the 
approval process for new drugs, and the adoption of new 
agents. The use of placebos is discussed, as are conflicts of 
interest in the conduct of clinical trials. The history of the 
FDA approval procedure isoutlined, along with the ethical 
foundations of the process. Brody succinctly summarizes 
the clinical conflicts that arise as a result of discrepancies 
between cost and clinical efficacy; for example, whether the 
marginal difference in mortality rate between streptoldnase 
and rt-PA for acute myocardial infarction is worth the 
enormous cost differential. The text closes with a brief 
discussion of pricing of drugs, including an alarming table 
that illustrates a four-fold differential between the relative 
price of drugs from one country to another. 
In summary, the book provides a concise and easily 
understandable text on the development and ethical con- 
cerns of thrombolysis for acute myocardial infarction. Al- 
though similar issues occur with predictable consistency 
with regard to all new pharmaceutical agents, this book is 
not likely to be of interest o peripheral vascular surgeons 
other than those who are intimately involved with throm- 
bolytic research. 
Kenneth Ouriel, MD 
University of Rochester 
Rochester, N.Y. 
Venous disorders: A manual of  diagnosis and 
treatment 
G. Belcaro, A. N. Nicolaides, and M. Veller, London, 
1995, W. B. Saunders, 204 pages, $35. 
This is an attractive, liberally illustrative, albeit modest, 
monograph on venous disorders. Although the first au- 
thor, Dr. Belcaro, will not be immediately familiar to many 
American readers, his credentials, especially his training 
and continued active involvement at St. Mary's Hospital in 
London, seem more than adequate to his subject. The 
book itself has a soft cover but is nicely produced on 
high-quality stock with liberal use of illustrations, many in 
color. However, it is only 183 pages in length, and thus 
most subjects are treated in a rather cursory fashion. The 
authors write with a clear, declarative style, and there is a 
short bibliography at the end of each subject. However, 
the chapters themselves are not referenced, which will be a 
problem for most critical readers. 
My biggest concern with this inexpensive ($35) British 
book was trying to identify the readers for whom it was 
intended. A brief "preface" on the back cover states: "This 
practical manual aims to provide a concise account of these 
(venous) disorders ufficiently detailed to ensure a sound 
understanding of the mechanisms involved and to provide 
effective clinical care . . .  Most importantly, guidance is 
provided throughout on the most reliable and widely ac- 
cepted management options." I would contend that it 
achieves few of these objectives. 
The authors begin with a brief account of the anatomy 
and physiology of the venous and lymphatic systems, 
which is well done, and then move on to review the 
important venous disease syndromes that affect both the 
lower and upper extremities. However, each subject is 
covered in such brief fashion that important omissions are 
inevitable. For example, the use of venous duplex scanning 
to diagnose and manage venous thrombosis so short that 
it is impossible for the reader to correctly appreciate how to 
perform this study, what its limitations are, and how it has 
revolutionized our management of this widespread condi- 
tion. In the discussion on prophylaxis of venous thrombo- 
sis in general surgical and urologic patients, the role of 
intermittent pneumatic compression is limited to the state- 
ment "Intermittent pneumatic ompression is also effec- 
five." Low molecular weight heparins are barely men- 
tioned, and there is no discussion of their use in the 
outpatient management of acute deep venous thrombosis. 
By contrast, here are relatively detailed escriptions of the 
surgical correction of venous valvular insufficiency and the 
Klippel-Trenaunay s ndrome, which seem out of place in a 
monograph such as this. 
I ultimately concluded that this book would be of 
greatest use to medical students, vascular laboratory tech- 
nicians, and  general surgical residents who wanted a 
greater understanding of its subject matter. However, it is 
much too cursory for vascular residents and certainly inad- 
equate for practicing vascular surgeons. 
Richard Kempczinski, MD 
University of Cincinnati Medical Center 
Cincinnati, Ohio 
Endoluminal stenting 
Ulrich Sigwart, Philadelphia, 1996, W. B. Saunders, 
621 pages, $79. 
Endoluminal stenting is edited by one of the leaders in 
the field and gives an overview of stent applications 
throughout he body. This 1996 publication offers the 
most complete summary available of the science behind 
